Stay updated on Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe latest updates include the posting of results for a study evaluating the feasibility and safety of combination therapy with Pembrolizumab in advanced stage, metastatic ovarian cancer, highlighting that the therapy was feasible and resulted in progression-free survival within historical ranges, while several previous metrics and outcome measures have been removed.SummaryDifference16%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check30 days agoNo Change Detected
- Check44 days agoChange DetectedThe website has been updated to version v2.10.0, adding options to show more conditions and interventions, and now includes information about 5 study locations.SummaryDifference0.5%
- Check51 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check56 days agoChange DetectedDifference0.2%
- Check57 days agoChange DetectedDifference0.2%
Stay in the know with updates to Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced Ovarian Cancer Clinical Trial page.